Literature DB >> 16528737

Non-lethal congenital hypotonia due to glycogen storage disease type IV.

T Andrew Burrow1, Robert J Hopkin, Kevin E Bove, Lili Miles, Brenda L Wong, Arabinda Choudhary, Deeksha Bali, Sing Chung Li, Yuan-Tsong Chen.   

Abstract

Glycogen storage disease type IV (GSD-IV) is an autosomal recessive genetic disorder due to a deficiency in the activity of the glycogen branching enzyme (GBE). A deficiency in GBE activity results in the accumulation of glycogen with fewer branching points and long, unbranched outer chains. The disorder results in a variable phenotype, including musculoskeletal, cardiac, neurological, and hepatic involvement, alone or in continuum, which can be identified at any stage of life. The classic form of GSD-IV is a hepatic presentation, which presents in the first 18 months of life with failure to thrive, hepatomegaly, and cirrhosis that progresses to liver failure, resulting in death by age 5 years. A severe congenital musculoskeletal phenotype with death in the neonatal period has also been described. We report an unusual case of congenital musculoskeletal presentation of GSD-IV with stable congenital hypotonia, gross motor delay, and severe fibro-fatty replacement of the musculature, but no hepatic or cardiac involvement. Molecular analysis revealed two novel missense mutations with amino acid changes in the GBE gene (Q236H and R262C), which may account for the mild phenotype. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16528737     DOI: 10.1002/ajmg.a.31166

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  8 in total

Review 1.  Glycogen metabolism and glycogen storage disorders.

Authors:  Shibani Kanungo; Kimberly Wells; Taylor Tribett; Areeg El-Gharbawy
Journal:  Ann Transl Med       Date:  2018-12

2.  Glycogen storage disease type IV: novel mutations and molecular characterization of a heterogeneous disorder.

Authors:  Sing-Chung Li; Chiao-Ming Chen; Jennifer L Goldstein; Jer-Yuarn Wu; Emmanuelle Lemyre; Thomas Andrew Burrow; Peter B Kang; Yuan-Tsong Chen; Deeksha S Bali
Journal:  J Inherit Metab Dis       Date:  2010-01-08       Impact factor: 4.982

3.  Neuropathological study of skeletal muscle, heart, liver, and brain in a neonatal form of glycogen storage disease type IV associated with a new mutation in GBE1 gene.

Authors:  C Lamperti; S Salani; S Lucchiari; A Bordoni; M Ripolone; G Fagiolari; M E Fruguglietti; V Crugnola; C Colombo; A Cappellini; A Prelle; N Bresolin; G P Comi; M Moggio
Journal:  J Inherit Metab Dis       Date:  2009-04-08       Impact factor: 4.982

4.  Neuromuscular forms of glycogen branching enzyme deficiency.

Authors:  C Bruno; D Cassandrini; S Assereto; H Orhan Akman; C Minetti; S Di Mauro
Journal:  Acta Myol       Date:  2007-07

5.  The potential of dietary treatment in patients with glycogen storage disease type IV.

Authors:  Terry G J Derks; Fabian Peeks; Foekje de Boer; Marieke Fokkert-Wilts; Hubert P J van der Doef; Marius C van den Heuvel; Edyta Szymańska; Dariusz Rokicki; Patrick T Ryan; David A Weinstein
Journal:  J Inherit Metab Dis       Date:  2020-12-21       Impact factor: 4.982

6.  Phylogenomic analysis of glycogen branching and debranching enzymatic duo.

Authors:  Christian M Zmasek; Adam Godzik
Journal:  BMC Evol Biol       Date:  2014-08-23       Impact factor: 3.260

7.  A novel approach to characterize phenotypic variation in GSD IV: Reconceptualizing the clinical continuum.

Authors:  Bridget T Kiely; Rebecca L Koch; Leticia Flores; Danielle Burner; Samantha Kaplan; Priya S Kishnani
Journal:  Front Genet       Date:  2022-09-13       Impact factor: 4.772

8.  Analysis of GBE1 mutations via protein expression studies in glycogen storage disease type IV: A report on a non-progressive form with a literature review.

Authors:  Hiroyuki Iijima; Reiko Iwano; Yukichi Tanaka; Koji Muroya; Tokiko Fukuda; Hideo Sugie; Kenji Kurosawa; Masanori Adachi
Journal:  Mol Genet Metab Rep       Date:  2018-09-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.